First Time Loading...
S

Santhera Pharmaceuticals Holding AG
SIX:SANN

Watchlist Manager
Santhera Pharmaceuticals Holding AG
SIX:SANN
Watchlist
Price: 9.25 CHF -0.96% Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

109.6m
+74%
Assets
Growth Rates:
1 Year
+72%
3 Years
+24%
5 Years
-
7 Years
-
10 Years
-
49.2m
-54%
Liabilities
Growth Rates:
1 Year
-54%
3 Years
-48%
5 Years
-
7 Years
-
10 Years
-
60.5m
Equity
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Santhera Pharmaceuticals Holding AG

109.6m
Assets
49.2m
Liabilities
109.6m
Assets
49.2m
Liabilities
Current Assets 34.7m
Cash & Short-Term Investments 30.4m
Receivables 2.2m
Other Current Assets 2.1m
Non-Current Assets 75m
Long-Term Investments 424k
PP&E 582k
Intangibles 74m
Current Liabilities 43.8m
Accounts Payable 5.6m
Accrued Liabilities 9.1m
Other Current Liabilities 29.1m
Non-Current Liabilities 5.4m
Long-Term Debt 35k
Other Non-Current Liabilities 5.3m

Balance Sheet
Santhera Pharmaceuticals Holding AG

Rotate your device to view
Balance Sheet
Currency: CHF
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
12
5
17
77
50
45
22
31
12
21
Cash
9
5
0
0
0
45
22
31
12
0
Cash Equivalents
4
0
17
77
50
0
0
0
0
21
Short-Term Investments
0
0
0
0
0
13
0
0
0
0
Total Receivables
1
0
1
2
4
5
8
9
4
2
Accounts Receivables
1
0
1
2
3
4
5
5
2
1
Other Receivables
0
0
0
1
1
1
2
4
2
1
Inventory
0
0
0
3
8
10
9
7
0
0
Other Current Assets
0
0
0
2
1
4
4
2
0
1
Total Current Assets
13
5
19
84
62
78
43
49
18
25
PP&E Net
0
0
0
0
1
2
2
6
2
1
PP&E Gross
0
0
0
0
1
2
2
6
2
1
Accumulated Depreciation
4
1
0
0
1
1
1
3
6
6
Intangible Assets
5
4
4
30
27
24
61
58
68
65
Long-Term Investments
0
0
0
0
0
1
1
1
1
0
Other Long-Term Assets
0
0
0
3
1
6
3
1
1
0
Total Assets
18
N/A
10
-47%
23
+137%
117
+410%
91
-23%
110
+21%
110
+0%
115
+4%
89
-23%
91
+3%
Liabilities
Accounts Payable
1
1
2
3
4
4
7
7
4
2
Accrued Liabilities
2
1
1
3
6
8
11
11
9
10
Short-Term Debt
0
0
0
0
0
0
0
0
11
1
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
1
1
14
Other Current Liabilities
0
0
1
0
1
2
1
5
5
5
Total Current Liabilities
3
2
3
7
10
13
20
24
29
33
Long-Term Debt
2
0
0
0
0
53
55
59
60
27
Other Liabilities
2
1
3
4
6
11
8
11
6
30
Total Liabilities
7
N/A
3
-62%
6
+119%
11
+91%
16
+51%
78
+372%
82
+6%
94
+14%
95
+1%
90
-6%
Equity
Common Stock
4
4
5
6
389
398
11
11
19
564
Retained Earnings
260
265
279
273
309
360
414
433
501
556
Additional Paid In Capital
274
275
294
377
0
0
436
448
480
0
Treasury Stock
0
0
0
0
0
0
1
1
2
5
Other Equity
7
6
2
4
6
6
3
4
3
1
Total Equity
11
N/A
7
-38%
17
+144%
106
+514%
74
-30%
32
-57%
28
-14%
21
-24%
6
N/A
1
N/A
Total Liabilities & Equity
18
N/A
10
-47%
23
+137%
117
+410%
91
-23%
110
+21%
110
+0%
115
+4%
89
-23%
91
+3%
Shares Outstanding
Common Shares Outstanding
4
4
5
6
6
6
1
1
2
50

See Also

Summary
SANN intrinsic value, competitors valuation, and company profile.
DCF Valuation
SANN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SANN stock valuation using valuation multiples.
Wall Street Estimates
SANN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SANN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.